Table 3.

Clinicopathological features of M‐NGA, common type gastric MALT lymphoma, and nodular gastritis

	M‐NGA (n = 4)	Common type (n = 20) $\left(\begin{array}{c}\text{Superficial}17\\ \text{Ulceration}2\\ \text{Elevated}1\end{array}\right)$	Nodular gastritis (n = 10)	P‐value $\left(\begin{array}{c}\text{M - NGA vs Common type}\\ \text{Common type vs Nodular gastritis}\\ \text{Nodular gastritis vs M - NGA}\end{array}\right)$
Age: average ± SD	40 ± 3.6	64 ± 12.6	38 ± 13	0.0012* 0.00011* 0.7427
Sex: male/female	4/0 (100%)	10/10 (50%)	7/3 (70%)	0.064 0.2974 0.22
API2‐MALT1 chimeric transcript: positive/negative	0/4 (0%)	1/19 (5%)	ND	0.6478 ND ND
HP infection: positive/negative	1/3 (25%)	15/5 (75%)	10/0 (100%)	0.053 0.083 0.002*
NHPH infection: positive/negative	4/0 (100%)	2/18 (10%)	0/10 (10%)	0.0001* 0.30 0.0002*
Effect of eradication therapy: CR/NC	4/0 (100%)	13/7 (65%)	10/0 (100%)	0.16 0.033 1

Abbreviations: CR, complete response; HP, Helicobacter pylori; M‐NGA, gastric MALT lymphoma with nodular gastritis‐like appearance; MALT, mucosa‐associated lymphoid tissue; NC, no change; ND, no data; NHPH, non‐H pylori Helicobacter.

^*Statistically significant (significance level = 0.05/3).